Simplified High-Performance Liquid Chromatography-Mass Spectrometry Assay for Measurement of Tacrolimus and Its Metabolites and Cross-Validation with Microparticle Enzyme Immunoassay
- 1 October 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 17 (5) , 504-510
- https://doi.org/10.1097/00007691-199510000-00011
Abstract
Summary In this study, a modified, specific assay for measurement of tacrolimus and its metabolites in blood and urine from transplant patients using high-performance liquid chromatography (HPLC) linked to mass spectrometry (MS) is described. Samples were prepared for HPLC-MS by modified solid-liquid extraction. The original two-step washing procedure was replaced by a single washing step, and samples were eluted with acetonitrile/water instead of dichloromethane, thus avoiding an evaporation step. Samples were injected automatically every 3 min into the HPLC-MS system. Time-consuming gradient elution was replaced by isocratic elution. This procedure resulted in a lower limit of quantitation of 0.2 μg/L. The interassay variability was 14.5% for 5 μg/L and 15.8% for 25 μg/L. The intraassay variability was 11.2% for 5 μg/L and 4% for 25 μg/L. The recovery for tacrolimus in blood was 90.4% for 1 μg/L, 78.9% for 10 μg/L, and 81.3% for 25 μg/L. Measurement of tacrolimus and its metabolites in samples from various transplant patients showed that the main metabolites found in blood and urine are demethyl-tacrolimus, di-demethyl-tacrolimus and demethyl-hydroxy-tacrolimus. Cross validation of the modified HPLC-MS assay with a microparticle enzyme immunoassay showed a significant correlation between the two assays, with r = 0.915.Keywords
This publication has 0 references indexed in Scilit: